APO-MEROPENEM meropenem (as trihydrate) 1000 mg powder for injection vial

País: Austràlia

Idioma: anglès

Font: Department of Health (Therapeutic Goods Administration)

ingredients actius:

meropenem trihydrate, Quantity: 1141 mg (Equivalent: meropenem, Qty 1000 mg)

Disponible des:

Arrotex Pharmaceuticals Pty Ltd

Designació comuna internacional (DCI):

Meropenem trihydrate

formulario farmacéutico:

Injection, powder for

Composición:

Excipient Ingredients: sodium carbonate

Vía de administración:

Intravenous

Unidades en paquete:

10 vials

tipo de receta:

(S4) Prescription Only Medicine

indicaciones terapéuticas:

Meropenem is indicated for treatment of the following infections, in adults and children (aged 3 months and over), when the causative organisms are known or suspected to be resistant to commonly used antibiotics: Community acquired lower respiratory tract infection; Hospital acquired lower respiratory tract infection; Complicated urinary tract infection; Febrile neutropenia; Intra-abdominal and gynaecological (poly microbial) infections; Complicated skin and skin structure infections; Meningitis; Septicaemia

Resumen del producto:

Visual Identification: White to slightly yellow powder; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Estat d'Autorització:

Licence status A

Data d'autorització:

2014-12-18